GALWAY, IRELAND--April 24, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Swiss pharmaceutical major Novartis International AG (NYSE:NVS) (Basel, Switzerland) has completed the planned spinoff of its Alcon eye-care business. Within this article: Details spinoff of Alcon business, Novartis shift to higher margin medicines, job cuts and proposed "blockbuster" medicines on the way
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
